Clinical Trial Investigators & Translational Research
Translational research transforms molecular discoveries from laboratory benches into life-saving therapies at the patient bedside. Precision Cancer Research Institute (PCRI) is recognized as a premier clinical trial site led by certified Principal Investigators — Dr. Anshul Agrawal and Dr. Dhruv Mehta — actively spearheading major national and global clinical trials in medical oncology.
Through our dedicated clinical trials infrastructure, PCRI provides cancer patients in South Gujarat and beyond with direct, ethical access to groundbreaking investigational drugs, next-generation targeted molecules, novel immunotherapies, and advanced biological biosimilars years before they become commercially available in standard practice.
Global Regulatory & Ethical Compliance
All clinical trials conducted at PCRI are governed by strict ethical and regulatory standards:
- Good Clinical Practice (ICH-GCP): Absolute adherence to international standards protecting patient safety, rights, confidentiality, and data integrity.
- Institutional Ethics Committee (IEC) Oversight: All trial protocols are vetted, approved, and continuously monitored by registered independent ethics review boards.
- DCGI & CDSCO Approvals: Full compliance with the Drugs Controller General of India and the Indian Council of Medical Research (ICMR) clinical trial guidelines.
Dedicated Clinical Research Infrastructure
- Full-Time Clinical Research Coordinators (CRCs): Dedicated research associates managing patient visits, protocol compliance, questionnaire documentation, and electronic case report forms (eCRFs).
- Investigational Product (IP) Pharmacy: Secure, temperature-mapped, access-controlled pharmacy storage with 24/7 digital logging for trial medications.
- Pharmacovigilance & Safety Monitoring: Real-time tracking, immediate recording, and swift clinical intervention for Adverse Events (AEs) and Serious Adverse Events (SAEs).
- Affordable Access to Novel Therapies: Eligible enrolled patients receive investigational drugs, associated specialized diagnostic scans, and clinical monitoring at no cost as per trial protocol sponsor guidelines.
Gallery
